CT
MN
VT
NV
WA
1. Deprioritization/ Decriminalization
N/A
Endorsed
N/A
Supported
N/A
2. Non-Commercial Peer Sharing
Opposed
Mixed
N/A
N/A
N/A
3. Commercial Sales
Opposed
Mixed
N/A
N/A
Supported
4. Religious Use Exemptions
N/A
Supported
N/A
N/A
Endorsed
5. Supervise Adult Use
Opposed
Endorsed
Opposed
Endorsed
Endorsed
6. Medical/ Therapeutic Use
Endorsed
Endorsed
Mixed
Endorsed
Endorsed
7. FDA-Approved Use
Endorsed
Opposed
N/A
Opposed
Opposed
8. State Monopoly Sales
N/A
N/A
N/A
N/A
N/A
1. Deprioritization/Decriminalization
CTN/A
MNEndorsed
VTN/A
NVSupported
WAN/A
2. Non-Commercial Peer Sharing
CTOpposed
MNMixed
VTN/A
NVN/A
WAN/A
3. Commercial Sales
CTOpposed
MNMixed
VTN/A
NVN/A
WASupported
4. Religious Use Exemptions
CTN/A
MNSupported
VTN/A
NVN/A
WAEndorsed
5. Supervised Adult Use
CTOpposed
MNEndorsed
VTOpposed
NVEndorsed
WAEndorsed
6. Medical/Therapeutic Use
CTEndorsed
MNEndorsed
VTMixed
NVEndorsed
WAEndorsed
7. FDA-Approved Use
CTEndorsed
MNOpposed
VTN/A
NVOpposed
WAOpposed
8. State Monopoly Sales
CTN/A
MNN/A
VTN/A
NVN/A
WAN/A